strongly associated with FLT3/ITD mutations. It is tempting to speculate that these cases are linked by a common underlying mutation that predisposes to DNA replication errors. What "unlinks" WT1 and NPM1 are their different prognostic influences. This study makes it clear that WT1 mutations are associated with unfavorable outcomes in childhood AML, as shown in the figure. Another important difference between WT1 and NPM1 mutations is that WT1 mutations retain prognostic significance in the presence of FLT3/ITD. While the favorable influence of NPM1 mutations appears to be "trumped" by FLT3/ITD, this study suggests that the unfavorable influence of FLT3/ITD may be "trumped" by wild-type WT1, since the outcome for FLT3/ITD ϩ patients who lacked WT1 mutations was not significantly worse than for patients with wild-type FLT3.
Itchy mast cells in MPNs ----------------------------------------------------------------------------------------------------------------
Ruben A. Mesa MAYO CLINIC In this issue of Blood, Ishii and colleagues investigate the role of mast cells in the pathogenesis of pruritus in patients with MPNs.
T he BCR-ABL-negative myeloproliferative neoplasms (MPNs) of polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) are characterized by a predisposition to thrombosis and hemorrhage, risk of blastic transformation, and premature death. In addition to these serious consequences, myeloproliferative disorder patients suffer variable constitutional symptoms, such as fatigue, bone pain, night sweats, and pruritus. 1 Data gathered from 1179 MPN patients reported that 81% suffer from pruritus, and this symptom was present in 72%, 84%, and 85% of ET, PMF, and PV patients, respectively. 1 The intensity of the pruritus can be severe, frequently exacerbated by water (ie, aquagenic pruritus), and has led some patients to discontinue bathing or to commit suicide in intractable cases. Therapy of MPN pruritus has been empiric, with antihistamines sometimes providing relief. Additionally, the use of selective serotonin reuptake inhibitors has been helpful, 2 and has suggested that platelets (the repository for serotonin in the blood) may have a role in MPN pruritus.
The pathogenesis of constitutional symptoms and particularly pruritus in MPN remains uncertain, despite recent insights into some aspects of molecular pathogenesis with identification of mutations that affect the JAK-STAT pathway including the JAK2 V617F , mutations in the 12th exon of JAK2, and mutations in cMPL. 3 Increased JAK2 allele burden has been associated with a greater burden of pruritus among PV patients, 4 although the exact mechanism for this association has remained uncertain, with speculation focusing on increased peripheral blood levels of cytokines. Additionally, investigators have investigated the various subsets of leukocytes that might be increased or activated in MPN patients. An association between the JAK2 mutation in basophils from PV patients, basophil activation, and degranulation with diseaseassociated pruritus was presented at the 2008 American Society of Hematology annual meeting. 5 Further work defining the role of basophils in the pathogenesis of MPN pruritus is ongoing.
Mast cells contain a variety of mediators of the inflammatory response (ie, histamine, tryptase, prostaglandins, and leukotrienes) that can generate pruritus. Ishii et al isolate peripheral blood mast cells as well as generating mast cells from CD34 ϩ cells of MPN patients suffering from pruritus, while not on cytoreductive therapy. 6 In their article in this issue of Blood, they make several salient observations. The first is that mast cells arising from MPN patients were functionally different from normal control mast cells in that they release greater levels of pruritogenic factors. Second, they observe that among patients with the most severe pruritus, (1) more mast cells are generated from CD34 ϩ cells, (2) their mast cells are less prone to apoptosis, and (3) they 
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have more marked increases in release of potentially pruritogenic cytokines. Finally, through use of the MPN mutation analysis, they demonstrate that mast cells from MPN patients are indeed offspring of the malignant clone, potentially explaining their functional differences from normal mast cells. These observations identify an intriguing target for therapy among MPN patients with significant pruritus, and further expand our knowledge of functional changes in leukocytes seen in MPN patients.
There is now accumulating evidence that mast cells, basophils, and even platelets may all play a role in MPN pruritus. Intriguingly, preliminary reports of JAK2 inhibitor therapy report significant decreases in pruritus, 7 and we can be hopeful that further discoveries regarding the pathogenesis of MPN pruritus may yield additional insight into the overall pathogenesis of MPNs. 
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Close encounters of the 3D kind   ---------------------------------------------------------------------------------------------------------------- 
Jens V. Stein UNIVERSITY OF BERN
The small GTPase Cdc42 is a key regulator of cell polarity. In this issue of Blood, Lämmermann and colleagues show that DCs without Cdc42 are still able to migrate fairly efficiently on 2-dimensional surfaces but become irreversibly entangled in 3-dimensional environments, both in vitro and in vivo. D endritic cells (DCs) are critical for the initiation of adaptive immune responses by taking up antigen in the periphery, such as skin, to present it to lymphocytes passing through draining peripheral lymph nodes (PLNs). To perform this task efficiently, activated DCs switch their sessile sampling behavior to a highly migratory one, characterized by the acquisition of a polarized phenotype and increased expression of the chemokine receptor CCR7, which responds to its ligands CCL19 and CCL21. 1 These changes are prerequisites for efficient DC migration into afferent lymphatic vessels, which secrete CCR7 ligands and serve as a communication highway to draining PLNs. 1 Small GTPases of the Rho and Ras families are key components of the induction and maintenance of a polarized phenotype and migration. Rac and Rho are involved in lamellipodia formation and uropod retraction, respectively. The Rho family member Cdc42 plays a role in induction and maintenance of polarity in various cell types, such as neutrophils and macrophages, in part through stabilization of the leading edge lamellipodia. 2 It remains unclear, however, how Cdc42 affected DC motility.
In this issue of Blood, Lämmermann et al report their findings on the role of Cdc42 during physiologic DC migration obtained in a series of elegant in vitro and in vivo assays. 3 Using primary mouse DCs derived from Cdc42-deficient bone marrow cultures, the authors investigate the migratory properties of these cells on 2-dimensional surfaces. Despite defects in maintaining polarity, Cdc42-deficient DCs still managed to migrate toward an increasing concentration of CCL19, with only slightly reduced migration velocities as compared with wild-type DCs (see top panel of figure) . The residual migratory capacity was likely due to largely intact Rac-induced spreading and lamellipodia formation. Thus, on 2-dimensional surfaces, Cdc42 was not absolutely required for directed cell motility.
In a second set of experiments, Lämmermann et al examine the importance of Cdc42 during DC migration in geometrically more complex environments, that is, the 3-dimensional fibrillar networks of collagen matrices in vitro and dermis in vivo. Somewhat unexpectedly, DCs lacking Cdc42 were strongly impaired in their directed motility in 3-dimensional environments in vitro (see bottom panel of figure) . Similarly, Cdc42-deficient DCs were entirely blocked in their migration from skin to draining PLNs, due to impaired entry into afferent lymphatic vessels. A more detailed morphologic analysis of Cdc42-deficient DCs uncovered that these cells became rapidly entangled within the 3-dimensional meshwork, with multiple protrusions pulling in different directions. Therefore, whereas migration efficiency in absence of Cdc42 was partially rescued due to the "lack of alternative routes" on 2-dimensional surfaces, cell motility in 3-dimensional environments absolutely required Cdc42.
Although the function of Cdc42 in other leukocytes was not addressed in this study, recent studies provide solid evidence for a Single cell trajectories of wild-type (WT) and Cdc42-deficient DCs migrating along a CCL19 gradient in 2-dimensional (top panel) and 3-dimensional (bottom panel) settings. Despite reduced directionality, Cdc42-deficient DCs were still able to migrate with residual efficiency on 2-dimensional surfaces. In contrast, lack of Cdc42 dramatically reduced cell displacement in 3-dimensional environments due to irreversible cell entangling. See the complete figure in the article beginning on page 5703.
